Subverted macrophages in the triple-negative breast cancer ecosystem

被引:6
|
作者
Shang, Linxiao [1 ]
Zhong, Yuting [2 ]
Yao, Yan [2 ]
Liu, Cun [3 ]
Wang, Lu [4 ]
Zhang, Wenfeng [5 ]
Liu, Jingyang [2 ]
Wang, Xue [4 ]
Sun, Changgang [6 ,7 ]
机构
[1] Binzhou Med Univ, Sch Integrated Tradit Chinese & Western Med, Yantai 264000, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250022, Peoples R China
[3] Weifang Med Univ, Coll Tradit Chinese Med, Weifang 261000, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250022, Peoples R China
[5] Macau Univ Sci & Technol, Sch Tradit Chinese Med, Macau 999078, Peoples R China
[6] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261000, Peoples R China
[7] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor -associated macrophage; Triple-negative breast cancer; Target; Immunosuppression; Subvert; TUMOR-ASSOCIATED MACROPHAGES; MONOCLONAL-ANTIBODY THERAPY; CHECKPOINT BLOCKADE; CELLS; MICROENVIRONMENT; POLARIZATION; RESISTANCE; RECEPTOR; NANOPARTICLES; PHAGOCYTOSIS;
D O I
10.1016/j.biopha.2023.115414
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor-associated macrophages (TAMs) are the most critical effector cells of innate immunity and the most abundant tumor-infiltrating immune cells. They play a key role in the clearance of apoptotic bodies, regulation of inflammation, and tissue repair to maintain homeostasis in vivo. With the progression of triple-negative breast cancer(TNBC), TAMs are "subverted" from tumor-promoting immune cells to tumor-promoting immune suppressor cells, which play a significant role in tumor development and are considered potential targets for cancer therapy. Here, we explored how macrophages, as the most important part of the TNBC ecosystem, are "subverted" to drive cancer evolution and the uniqueness of TAMs in TNBC progression and metastasis. Similarly, we discuss the rationale and available evidence for TAMs as potential targets for TNBC therapy.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer
    Padzinska-Pruszynska, Irena
    Kucharzewska, Paulina
    Matejuk, Agata
    Gorczak, Malgorzata
    Kubiak, Malgorzata
    Taciak, Bartlomiej
    Krol, Magdalena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)
  • [2] Imaging of triple-negative breast cancer
    Dogan, B. E.
    Turnbull, L. W.
    ANNALS OF ONCOLOGY, 2012, 23 : 23 - 29
  • [3] Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages
    Mei, Mei
    Tang, Linfeng
    Zhou, Hao
    Xue, Nina
    Li, Ming
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 959
  • [4] Immunotherapy for Triple-Negative Breast Cancer
    Cao, Yifeng
    Chen, Chuyang
    Tao, Yi
    Lin, Weifeng
    Wang, Ping
    PHARMACEUTICS, 2021, 13 (12)
  • [5] Nanomaterials for the Diagnosis and Treatment of Triple-Negative Breast Cancer
    Sun, Xuan
    Li, Dandan
    Lv, Yue
    Zhang, Mengnan
    Qiao, Dianhe
    Zhang, Zuyuan
    Ren, Han
    Zhang, Ying
    Yang, Zhimou
    Gao, Jie
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2024, 16 (06)
  • [6] New Achievements for the Treatment of Triple-Negative Breast Cancer
    Catalano, Alessia
    Iacopetta, Domenico
    Ceramella, Jessica
    Mariconda, Annaluisa
    Rosano, Camillo
    Scumaci, Domenica
    Saturnino, Carmela
    Longo, Pasquale
    Sinicropi, Maria Stefania
    APPLIED SCIENCES-BASEL, 2022, 12 (11):
  • [7] Triple-negative breast cancer
    Stockmans, Gert
    Deraedt, Karen
    Wildiers, Hans
    Moerman, Philippe
    Paridaens, Robert
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 614 - 620
  • [8] Multifunctional nanoparticles inhibit tumor and tumor-associated macrophages for triple-negative breast cancer therapy
    Liu, Yan
    Zhang, Dan
    Zhang, Zongquan
    Liang, Xiaoya
    Yang, Xi
    Ding, Nianhui
    Nie, Yu
    Li, Chunhong
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2024, 657 : 598 - 610
  • [9] Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE
    Qiao, Jianghua
    Chen, Yibing
    Mi, Yanjun
    Jin, Huan
    Wang, Lina
    Huang, Ting
    Li, Haolong
    Song, Yucen
    Cao, Jun
    Wu, Baoyan
    Wang, Qiming
    Zou, Zhengzhi
    BIOCHEMICAL PHARMACOLOGY, 2020, 180
  • [10] Understanding the biology of triple-negative breast cancer
    Criscitiello, C.
    Azim, H. A., Jr.
    Schouten, P. C.
    Linn, S. C.
    Sotiriou, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 13 - 18